Demonstration venue · read-only. Every page can be browsed; the buttons that would change it are switched off. Create an account to run TaxoReview on your own data. A simulation from public publication records: the people listed were not invited and did not agree to review.
? Tutorial for this page

Sudeep Sarma

dblp:429/6712 · DBLP profile ↗
← Back
1ranked-venue papers
0as first author
1since 2021 · last 2026
0000-0002-4642-7689ORCID · reported

Domains — the database's venue-derived domains; a paper can count in several

Artificial intelligence and machine learning · 1 · 1 since 2021Graphics, computer vision, multimedia, augmented reality and games · 1 · 1 since 2021

Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.

Interdisciplinary, comprehensive, and emerging computing
1 paper
Bioinformatics and computational biology · 50% Medical and health informatics · 50%
Artificial intelligence
1 paper
Learning paradigms · 100%

Topics — the 2 heaviest of 3, each with the papers that count most for it

TopicWeightPapersLastEvidence papers
Bioinformatics and computational biology
protein-protein interaction prediction
1.012026
Machine Learning Models Assisting the Development of Antibody Therapeutics and Vaccines - an Emerging Trend · AAAI 2026
Machine learning › Learning paradigms › supervised learning
property prediction
0.312026
Machine Learning Models Assisting the Development of Antibody Therapeutics and Vaccines - an Emerging Trend · AAAI 2026

Methods — techniques the papers use, named apart from their topics

machine learning property prediction · 2.0
YearPublicationVenuePosition
2026 Machine Learning Models Assisting the Development of Antibody Therapeutics and Vaccines - an Emerging Trend
abstract
The development of novel effective medical treatments is one of the most important and expected beneficial effects of the AI revolution. This decade is witnessing the rise of AI models able to predict complex properties for protein-protein interactions that hold great promise in assisting in the development of antibody therapeutics and vaccines, including for diseases that long eluded us in the pursuit of an effective treatment. This paper introduces this area of research in a language accessible to an AI researcher, exploring the biological problems that can be solved by AI models, as well as the general context to make solutions feasible in practical scenarios. We survey the main current trends and works in this research area and point towards current still unsolved challenges and trade offs. We expect this paper will be extremely helpful for AI researchers trying to join the field, as well as for researchers already working in one of the subtopics that wish to have a better understanding of the general context around it.
Felipe Leno da Silva, Mikel Landajuela, Edwin A. Saada, Piyush Karande, Sudeep Sarma, Igor D'Angelo, Simone Conti, Daniel M. Faissol
AAAI5